Media

Objective, real time diagnosis

When needed Where needed

Media

read more

Med-Tech Innovation 04/11/2014: UK and Singapore collaboration delivers a world first in diagnostics 20/11/2014

Product design and development firm Cambridge Consultants is working with Singapore-based start-up Endofotonics on a groundbreaking endoscopic instrument development to improve pre-cancer diagnosis. It’s the world’s first device to give clinicians real-time molecular diagnosis from inside the body. – See more at: http://www.med-techinnovation.com/News/home/news/1169#sthash.3yMzo3EP.dpuf

read more

Business Weekly 4th Nov 2014: TECH SPY INSIDE THE BODY WILL DIAGNOSE CANCER FASTER 20/11/2014

A fibre optic probe inserted inside the body to capture the molecular fingerprint of tissue is being commercially developed by Cambridge Consultants and client – Singapore startup Endofotonics – to help doctors make real-time diagnoses of stomach and bowel cancer.

read more

Cambridge Network 4/11/2014: Cambridge Consultants develops a world first in diagnostics 20/11/2014

Product design and development firm Cambridge Consultants is working with Singapore-based start-up Endofotonics on a groundbreaking endoscopic instrument development to improve pre-cancer diagnosis. It’s the world’s first device to give clinicians real-time molecular diagnosis from inside the body.

read more

Medical Physics Web: Nov 13, 2014: Raman device diagnoses from inside the body 19/11/2014

Product development firm Cambridge Consultants is working with Singapore-based start-up Endofotonics to create a real-time in vivo molecular diagnostic (IMDX) system.

read more

New NUS spin-off company to reduce cancer death and disease burden through real time cancer diagnosis 16/04/2014

Endofotonics Pte Ltd, an NUS spin-off company, issued a joint press release with NUS to announce its launch. Endofotonics’ launch generated coverage in more than 260 media including Reuters, Yahoo Finance and The Business Journal.

read more

NUS Biomedical Engineering team pioneers world’s first real time in-vivo molecular diagnostic system that diagnoses even pre-cancerous tissues during endoscopy 10/02/2014

The NUS developed in-vivo molecular diagnostic system was unveiled in a media briefing on 10th February 2014 and was attended by more than fifteen medical journalists. Media interest in the IMDX system was reflected in the interactive Q&A session. Extensive broadcast and print coverage was achieved in both local and international media, including CNA, Devicespace and Advance Healthcare Network